-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $51

Benzinga·09/17/2026 10:24:18
Listen to the news
Stifel analyst Alex Thompson initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Buy rating and announces Price Target of $51.